Nephrocare Health IPO
Alloted
Nephrocare Health Services Ltd., founded in 2010, is India’s and Asia’s largest dialysis chain, providing complete dialysis care, including haemodialysis, home/mobile dialysis, and wellness programs. The company operates 519 clinics globally (51 internationally) and approximately 78% of its Indian clinics are located in Tier II and III cities. Nephrocare follows an asset-light model, partnering with major hospital chains like Max, Fortis, and Care Hospitals. The company has a track record of growth, profitability, and positive returns since recovering from losses in FY23.
Issue Price
460
Current GMP
₹37 (8.04%)
Overall Subscription
14.08x
Issue Size
₹871.05 Cr
Advertisement
Live Subscription by Application
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 37,68,224 | 265 | 0.00x |
FII | - | 25 | - |
DFI | - | 21 | - |
MF | - | 66 | - |
Other | - | 153 | - |
| NII | 6,312 | 53,403 | 8.46x |
bNII | 4,208 | 25,721 | 6.11x |
Corporate | - | 350 | - |
Individual | - | 24,262 | - |
Other | - | 1,109 | - |
sNII | 2,104 | 27,682 | 13.16x |
Corporate | - | 30 | - |
Individual | - | 26,555 | - |
Other | - | 1,097 | - |
| Retail | 2,06,197 | 4,02,091 | 1.95x |
Cut-off price | - | 3,29,147 | - |
Fixed price | - | 72,944 | - |
| Employee | 2,610 | 3,770 | 1.44x |
Cut-off price | - | 3,345 | - |
Fixed price | - | 425 | - |
| Total | 39,83,343 | 4,59,529 | 0.12x |
Live Subscription by Shares
| Category | Shares Offered | Shares Applied | Subscription |
|---|---|---|---|
| QIB | 37.68 L | 10.11 Cr | 26.82x |
FII | - | 2.69 Cr | - |
DFI | - | 1.91 Cr | - |
MF | - | 1.92 Cr | - |
Other | - | 3.59 Cr | - |
| NII | 28.28 L | 7.01 Cr | 24.77x |
bNII | 18.85 L | 5.74 Cr | 30.43x |
Corporate | - | 8.44 L | - |
Individual | - | 5.41 Cr | - |
Other | - | 24.32 L | - |
sNII | 9.43 L | 1.27 Cr | 13.46x |
Corporate | - | 15.84K | - |
Individual | - | 1.22 Cr | - |
Other | - | 4.99 L | - |
| Retail | 65.98 L | 1.55 Cr | 2.35x |
Cut-off price | - | 1.28 Cr | - |
Fixed price | - | 27.45 L | - |
| Employee | 83.53K | 2.35 L | 2.81x |
Cut-off price | - | 1.80 L | - |
Fixed price | - | 55.01K | - |
| Total | 1.33 Cr | 18.69 Cr | 14.08x |
Subscription Summary
QIB
Shares Applied:26.82x
Applications Offered:0.00x
NII
Shares Applied:24.77x
Applications Offered:8.46x
Retail
Shares Applied:2.35x
Applications Offered:1.95x
Employee
Shares Applied:2.81x
Applications Offered:1.44x
Quick Stats
Total Categories4
IPO TypeMainboard
StatusAllotment Out
Join us on Telegram for instant IPO updates!
Join NowData Last Updated
15 Dec 2025, 01:22 pm
Auto-refreshing
Advertisement
Understanding Subscription Categories
QIB
Qualified Institutional Buyers
Includes FII, DFI, Mutual Funds, and other qualified institutions.
NII
Non-Institutional Investors
High net-worth individuals: bNII (₹10L+) and sNII (₹2L-₹10L).
Retail
Retail Individual Investors
Retail investors with applications up to ₹2 lakh per PAN.
Frequently Asked Questions
What is the current subscription status of Nephrocare Health IPO?
The current overall subscription for Nephrocare Health IPO is 14.08x. This indicates the total demand relative to the shares offered. Higher subscription typically suggests strong investor interest.
How to check Nephrocare Health IPO subscription status?
You can check Nephrocare Health IPO subscription status on IPOwiz, BSE website, NSE website, or your broker's platform. Subscription data is updated regularly during the IPO period from 10 December 2025 to 12 December 2025.
What do subscription numbers mean?
Subscription numbers show how many times the IPO is oversubscribed. For example, 14.08x means the IPO received 14.08x times more applications than shares available. Higher subscription in retail category generally means lower allotment chances.
When does Nephrocare Health IPO subscription close?
The subscription for Nephrocare Health IPO closes on 12 December 2025. Applications must be submitted before the closing time on this date. Late applications will not be accepted.
What is the difference between QIB, NII, and Retail subscription?
QIB (Qualified Institutional Buyers) includes mutual funds, FIIs, and other institutions. NII (Non-Institutional Investors) includes high net-worth individuals investing above ₹2 lakh. Retail includes individual investors with applications up to ₹2 lakh. Each category has separate subscription quotas.
How does subscription affect allotment chances?
Higher subscription in your category means lower allotment chances. For example, if retail subscription is 14.08x, it means there are 14.08x times more applications than shares available, making allotment competitive.
When will Nephrocare Health IPO allotment be finalized?
The allotment for Nephrocare Health IPO will be finalized and announced on 15 December 2025. You can check your allotment status on the registrar's website, BSE, NSE, or your demat account after this date.
What happens after subscription closes?
After subscription closes on 12 December 2025, the company and registrar process all applications. Allotment is finalized by 15 December 2025, and shares are credited to successful applicants' demat accounts before the listing date on 17 December 2025.
Can I apply after subscription closes?
No, you cannot apply after the subscription closes on 12 December 2025. All IPO applications must be submitted during the subscription period from 10 December 2025 to 12 December 2025. Late applications are automatically rejected.
What is the issue size and lot size for Nephrocare Health IPO?
The issue size for Nephrocare Health IPO is ₹871.05 Cr, and the lot size is 32 shares. The price range is ₹438.0 - ₹460.0. You must apply in multiples of the lot size.